These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
625 related articles for article (PubMed ID: 15164161)
1. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure. Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161 [TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Ueda M; Inaba M; Okuno S; Nagasue K; Kitatani K; Ishimura E; Shimizu M; Miki T; Kim M; Nishizawa Y Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients. Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383 [TBL] [Abstract][Full Text] [Related]
4. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. Katagiri M; Fukunaga M; Ohtawa T; Harada T World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946 [TBL] [Abstract][Full Text] [Related]
5. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients. Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741 [TBL] [Abstract][Full Text] [Related]
6. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265 [TBL] [Abstract][Full Text] [Related]
7. Cross-sectional evaluation of bone metabolism in men. Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833 [TBL] [Abstract][Full Text] [Related]
8. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results. Lumachi F; Orlando R; Fallo F; Basso SM In Vivo; 2012; 26(6):1041-4. PubMed ID: 23160690 [TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients. Maeno Y; Inaba M; Okuno S; Yamakawa T; Ishimura E; Nishizawa Y Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890 [TBL] [Abstract][Full Text] [Related]
10. Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D. Obatake N; Ishimura E; Tsuchida T; Hirowatari K; Naka H; Imanishi Y; Miki T; Inaba M; Nishizawa Y J Bone Miner Metab; 2007; 25(1):74-9. PubMed ID: 17187197 [TBL] [Abstract][Full Text] [Related]
11. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488 [TBL] [Abstract][Full Text] [Related]
12. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479 [TBL] [Abstract][Full Text] [Related]
13. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944 [TBL] [Abstract][Full Text] [Related]
14. Serum adiponectin and bone mineral density in male hemodialysis patients. Okuno S; Ishimura E; Norimine K; Tsuboniwa N; Kagitani S; Yamakawa K; Yamakawa T; Sato KK; Hayashi T; Shoji S; Nishizawa Y; Inaba M Osteoporos Int; 2012 Jul; 23(7):2027-35. PubMed ID: 21927917 [TBL] [Abstract][Full Text] [Related]
15. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients. Ebert W; Muley T; Herb KP; Schmidt-Gayk H Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610 [TBL] [Abstract][Full Text] [Related]
16. Relationship of bone turnover to bone density and fractures. Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008 [TBL] [Abstract][Full Text] [Related]
17. The impact of subcutaneous oestradiol implants on biochemical markers of bone turnover and bone mineral density in postmenopausal women. Pereda CA; Hannon RA; Naylor KE; Eastell R BJOG; 2002 Jul; 109(7):812-20. PubMed ID: 12135219 [TBL] [Abstract][Full Text] [Related]
18. Changes in bone mass and bone turnover following distal forearm fracture. Ingle BM; Hay SM; Bottjer HM; Eastell R Osteoporos Int; 1999; 10(5):399-407. PubMed ID: 10591838 [TBL] [Abstract][Full Text] [Related]
19. Chronic idiopathic neutropenia of adults is associated with decreased bone mineral density and alterations in bone turnover biochemical markers. Papadaki HA; Margioris AN; Miliaki M; Steriopoulos C; Valatas W; Eliopoulos GD Eur J Haematol; 1999 May; 62(5):311-6. PubMed ID: 10359059 [TBL] [Abstract][Full Text] [Related]
20. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. Ureña P; Ferreira A; Kung VT; Morieux C; Simon P; Ang KS; Souberbielle JC; Segre GV; Drüeke TB; De Vernejoul MC J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]